Interventions of Interest

  • ensifentrine (Ohtuvayre, Verona Pharma)

Chronic obstructive pulmonary disease (COPD) is a group of lung diseases characterized by
progressive and persistent airflow obstruction in the lungs. COPD affects approximately 15.7
million people in the United States, with higher rates among non-Hispanic White individuals, Native American individuals, women, and adults older than 65.

For questions please contact Liis Shea, Senior Program Director,

View the Key Stakeholder List.